1. and 2. Emmanuelle Charpentier and Jennifer A. Doudna Emmanuelle Charpentier and Jennifer A. Doudna shared the Nobel Prize in Chemistry for their work on developing the CRISPR-Cas9 gene-editing tools. This technology has limitless applications and researchers hope...
The vast majority of people diagnosed with colon cancer are over the age of 50. In fact, the average age of colon cancer diagnoses in the United States is 68 for men and 72 for women. However, colon cancer can and does occur in people in their teens, 20s, 30s, and...
This is part of a series of articles written to highlight rare hereditary cancer syndromes. In this interview, Heather shares her story of living with Cowden syndrome. Genetic Counseling Note: People who have a mutation (also known as a pathogenic variant) in the PTEN...
Dr. William G. Kaelin, Jr., Sir Peter J. Ratcliffe, and Dr. Gregg L. Semenza won the 2019 Nobel Prize in Physiology or Medicine for their work related to a genetic condition called von Hippel-Lindau syndrome (VHL). VHL is a hereditary cancer syndrome that is...
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...